전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-3 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,403 programs
ADCLimited DatastalePfizerPhase 3

INO (Inotuzumab ozogamicin, Inotuzumab ozogamicin (INO))

B-Cell Acute Lymphoblastic Leukaemia · B-Cell Acute Lymphoblastic Leukaemia

#B-CellAcuteLymphoblasticLeukaemi#ADC#Phase3#antibody-drug-conjugate#Pfizer
Trials 1Status Recruiting
CGTLimited DatastaleWenbin QianPhase 2

Interleukin-7 and Chemokine (C-C Motif, Interleukin-7 and Chemokine, Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T cells)

B Cell Lymphoma · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active
AntibodyLimited DatastaleNorthwell HealthPhase 1

trastuzumab (Herceptin, Intra-arterial Cerebral Infusion of Trastuzumab)

Neoplasm Metastasis · Neoplasm Metastasis

#NeoplasmMetastasis#Antibody#Phase1#monoclonal-antibody#Northwell
Trials 1Status Discontinued
AntibodyLimited DatastaleEli LillyPhase 2

Intra-arterial Cetuximab (Intra-arterial Cetuximab)

Glioblastoma; Anaplastic Astrocytoma · Glioblastoma

#Glioblastoma#Antibody#Phase2#monoclonal-antibody#AnaplasticAstrocytoma+1
Trials 1Status Recruiting
AntibodyLimited DatastaleJanssenPhase 3

Intraarticular injection of infliximab (Intraarticular injection of infliximab)

Arthritis · Arthritis

#Arthritis#Antibody#Phase3#monoclonal-antibody#Janssen
Trials 1Status Discontinued
CGTLimited DatastaleT-MAXIMUM Pharmaceutical IncPhase 2

Intracerebroventricular injection of MT027 UCAR-T Cell targeting B7H3 (Intracerebroventricular injection of MT027 UCAR-T Cell targeting B7H3)

Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype · Glioblastoma IDH (Isocitrate Dehydrogena

#GlioblastomaIDHIsocitrateDehydro#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
AntibodyLimited DatastaleKhon Kaen UniversityPhase 3

Intralesional injection of bevacizumab (Intralesional injection of bevacizumab)

Pterygium; Inflammation · Pterygium

#Pterygium#Antibody#Phase3#monoclonal-antibody#Inflammation+1
Trials 1Status Active
AntibodyLimited DatastaleHospices Civils de LyonPhase 2

nivolumab (Opdivo, IP, Intraperitoneal, Intraperitoneal (IP) nivolumab infusion)

Ovarian Cancer · Ovarian Cancer

#OvarianCancer#Antibody#Phase2#monoclonal-antibody#Hospices
Trials 1Status Active
AntibodyLimited DatastaleEastern Regional Medical CenterPhase 1

Intraperitoneal Bevacizumab (Intraperitoneal Bevacizumab)

Malignant Ascites · Malignant Ascites

#MalignantAscites#Antibody#Phase1#monoclonal-antibody#Eastern
Trials 1Status Discontinued
AntibodyLimited DatastaleRochePhase 2

Intrathecal Rituximab (Intrathecal Rituximab)

Leukemia; Lymphoid Malignancies · Leukemia

#Leukemia#Antibody#Phase2#monoclonal-antibody#LymphoidMalignancies+1
Trials 1Status Discontinued
AntibodyLimited DatastaleShanghai Cancer Hospital, ChinaPhase 2

nivolumab (Opdivo, Intraventricular Nivolumab)

Leptomeningeal Metastasis · Leptomeningeal Metastasis

#LeptomeningealMetastasis#Antibody#Phase2#monoclonal-antibody#Shanghai
Trials 1Status Recruiting
CGTLimited DatastaleUNC Lineberger Comprehensive Ca…Phase 2

Investigational CAR-T (Investigational CAR-T)

Malignancy; Cancer · Malignancy

#Malignancy#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Discontinued
CGTLimited DatastaleChongqing Precision Biotech Co.…Phase 1

Invivo CAR-T (Invivo CAR-T)

B-Acute Lymphoblastic Leukemia; B Cell Non-Hodgkin's Lymphoma · B-Acute Lymphoblastic Leukemia

#B-AcuteLymphoblasticLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
AntibodyLimited DatastaleSir Run Run Shaw HospitalPhase 2

Ipalolimab and Tovorilimab (Ipalolimab and Tovorilimab)

dMMR/MSI-H-type Rectal Adenocarcinoma · dMMR/MSI-H-type Rectal Adenocarcinoma

#dMMRMSI-H-typeRectalAdenocarcino#Antibody#Phase2#monoclonal-antibody#dMMR+2
Trials 1Status Recruiting
AntibodyLimited DatastaleTianjin Medical University Canc…Phase 2

Iparomlimab and tuvonralimab (Iparomlimab and tuvonralimab)

HCC - Hepatocellular Carcinoma; Iparomlimab and Tuvonralimab Injection · mCRC

#mCRC#Antibody#Phase2#monoclonal-antibody#HCC-HepatocellularCarcinoma+2
Trials 1Status Recruiting
AntibodyLimited DatastaleBristol Myers SquibbPhase 2

Ipilimumab IT (Ipilimumab IT)

Stage III/IV Melanoma · Stage III/IV Melanoma

#StageIIIIVMelanoma#Antibody#Phase2#monoclonal-antibody#StageIII+2
Trials 1Status Active
AntibodyLimited DatastaleBristol Myers SquibbPhase 2

Ipilimumab Injection [Yervoy] (Ipilimumab Injection [Yervoy])

Malignant Melanoma · Malignant Melanoma

#MalignantMelanoma#Antibody#Phase2#monoclonal-antibody#Bristol
Trials 1Status Recruiting
AntibodyLimited DatastaleBristol Myers SquibbPhase 2

Ipilimumab and Fotemustine (Ipilimumab and Fotemustine)

Metastatic Malignant Melanoma · Metastatic Malignant Melanoma

#MetastaticMalignantMelanoma#Antibody#Phase2#monoclonal-antibody#Bristol
Trials 1Status Active
AntibodyLimited DatastaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, Ipilimumab plus nivolumab plus guadecitabine)

Melanoma; Non Small Cell Lung Cancer · Melanoma

#Melanoma#Antibody#Phase2#monoclonal-antibody#NonSmallCellLungCancer+1
Trials 1Status Active
AntibodyLimited DatastaleBristol Myers SquibbPhase 2

pembrolizumab (Keytruda, Ipilimumab, Nivolumab, Pembrolizumab or Atezolizumab)

Metastatic Cancer; Melanoma Cancer · Metastatic Cancer

#MetastaticCancer#Antibody#Phase2#monoclonal-antibody#MelanomaCancer+1
Trials 1Status Recruiting

83 / 121 pages

← PreviousNext →